Navigation Links
Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
Date:1/9/2008

nts. These diseases are mediated by activated T-cells, which rely on JAK3 signaling.

Current treatments for these diseases include steroids, methotrexate and various injectable biologic agents. Rigel's product candidate, R348, is believed to be orally bio-available and may provide an attractive alternative or supplement to currently used agents.

R348 is also being studied as a potential treatment for transplant rejection and graft vs. host disease.

About Rigel (http://www.Rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the potential efficacy and commercial potential of R348 and Rigel's plans to pursue further clinical development thereof. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "plans," "potential," and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking sta
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 ... appointments of Dr. Ashraf Hanna , M.D., Ph.D., ... its Board of Directors. Dr. Hanna is the Vice ... and Chief Financial Officer for the Genentech Foundation, while ... Global Head of Business Development and Licensing for Roche ...
(Date:9/18/2014)... , Sept. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to the position of  Senior Director of Clinical Development. ... Mr. James has established and led successful global clinical ... , to facilitate the clinical development of numerous ...
(Date:9/18/2014)... Sept. 18, 2014 /CNW/ - A new expert panel report, ... , released today by the Council of ... effective medicines for children. Each year about half of ... at least one prescription drug. Much of this prescribing ... authorized use), creating potential health risks. Children ...
Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
(Date:9/18/2014)... 18, 2014 Alexandria, VA — The ... that 10 more communities have joined the growing ranks ... department accreditation. The decisions bring the number of governmental ... PHAB is the non-profit organization that administers the national ... protect the health of the public by advancing the ...
(Date:9/18/2014)... THURSDAY, Sept. 18, 2014 (HealthDay News) -- Older people ... That,s because the balance of stress hormones during ... result, older people who are grieving are more likely ... study found. "During the difficult weeks and months ... Neutrophils are the most abundant type of white blood ...
(Date:9/18/2014)... San Luis Obispo, CA (PRWEB) September 18, 2014 ... Bunion Bootie introduced their newest, patent pending bunion splint ... , As one loyalist, Rosa, wrote: "I was absolutely delighted. ... comfortable... I honestly forget I am wearing them. THANK YOU ... the recently introduced design by saying, "The hole used to ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter ... it comes to emergency room waiting times, patients seeking care ... staring down the clock than those seen at smaller or ... crowding and our ability to provide timely emergency care varies ... the authors of the new research, Dr. Renee Hsia, an ...
(Date:9/18/2014)... Physicians (CHEST) together with the Chinese Thoracic Society ... CTS that CHEST World Congress 2016 will be ... care, and sleep medicine from around the world ... for spring 2016. , CHEST World Congress ... simulation training, keynote addresses, presentations by leading health-care ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:CHEST announces China as site of CHEST World Congress 2016 2
... Research from the University of Sheffield has found that people are ... per year, for greener urban spaces. Researchers surveyed the public ... find out how much extra they were willing to pay in ... area. They found that people were willing to pay more for ...
... group of researchers at the University of California, San Francisco ... and red serpent called the Texas coral snake can be ... and acute pain and provides new research tools that ... The venom contains a toxic mixture of chemicals that includes ...
... , THURSDAY, Nov. 17 (HealthDay News) -- Young athletes who ... -- even if they do not suffer a concussion, according ... from the University of Rochester Medical Center (URMC) said their ... consequences of seemingly mild head injuries among young people whose ...
... -- An international team of researchers led by clinicians at ... in an aggressive type of prostate cancer -- a vulnerability ... is already in clinical trials to treat other types of ... the researchers report that the investigational drug had a dramatic ...
... Gordon HealthDay Reporter , WEDNESDAY, Nov. 16 ... mofetil (CellCept) is better at controlling a serious kidney ... new study suggests. People taking mycophenolate were about ... were people taking azathioprine (Imuran), according to the researchers. ...
... Gardner HealthDay Reporter , WEDNESDAY, Nov. 16 (HealthDay ... healthy have a good chance of staving off cancer as ... maintain a healthy body-mass index (BMI), normal blood pressure and ... a 38 percent lower risk of developing cancer, according to ...
Cached Medicine News:Health News:Public willing to pay more for greener urban spaces 2Health News:Public willing to pay more for greener urban spaces 3Health News:Snake spills venomous secrets 2Health News:Snake spills venomous secrets 3Health News:Routine Head Hits in Sports May Injure Brain, Experts Warn 2Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 2Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 3Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 4Health News:Newer Drug Seems Better at Controlling Lupus Kidney Complication 2Health News:Newer Drug Seems Better at Controlling Lupus Kidney Complication 3Health News:Healthy Heart Habits May Also Guard Against Cancer 2Health News:Healthy Heart Habits May Also Guard Against Cancer 3
... This sleek, contoured instrument table ... room dcor, while providing a sturdy, ... wheelchair compatible design provides completely open ... make positioning quick and easy. The ...
... projection, in shorter exam lanes, where images from ... Thirty individual charts are available. Charts are controlled ... the CV-3000 Vision Testing System, using the CV ... either a single letter, horizontal line or vertical ...
... new product has generated lots of interest, ... most efficient instruments in Ophthalmology and Optometry ... system can present the auto refractor values ... space efficiencyfits comfortably in a 7' X ...
... Topcon offers an all-metal Trial Frame that ... a practical screw-thread design that extends the ... for easy replacement of springs and other ... frame snugly yet comfortably on the patients ...
Medicine Products: